Breast Cancer
Clinical Review
An ObGyn’s guide to aromatase inhibitors as adjuvant therapy for breast CA
You may not prescribe anastrozole, letrozole, or exemestane, but there’s a strong possibility that some of your patients are taking one of these...
Expert Commentary
Is new-onset breast tenderness after the start of hormone therapy a sign of elevated cancer risk?
Yes.
Clinical Review
Confused about mammography guidelines? 7 questions answered
Breast cancer screening recommendations issued by the US Preventive Services Task Force succeeded—in clouding what’s best, for whom. But the air...
Clinical Review
The case for chemoprevention as a tool to avert breast cancer
Women at high risk of invasive breast cancer can elect chemoprevention with tamoxifen or raloxifene. An aromatase inhibitor may one day be an...